Hong Tang

Switching from entecavir to PegIFN alfa-2a in patients with HBeAg-positive chronic hepatitis B: A randomised open-label trial (OSST trial)

Qin Ning, Meifang Han, Yongtao Sun et al. · Journal of Hepatology · 2014 · 270 citations

Pegifn Alfa-2a, Hepatology, Viral Hepatitis +8

Long-Term Treatment With Entecavir Induces Reversal of Advanced Fibrosis or Cirrhosis in Patients With Chronic Hepatitis B

Eugene R. Schiff, Samuel S. Lee, You‐Chen Chao et al. · Clinical Gastroenterology and Hepatology · 2010 · 193 citations

Promoter analysis in living zebrafish embryos identifies a cis-acting motif required for neuronal expression of GATA-2

Anming Meng, Hong Tang, Bruce A. Ong et al. · Proceedings of the National Academy of Sciences · 1997 · 182 citations

Gfp Expression, Promoter Analysis, Transcriptional Regulation +14

Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism

Hong Tang, A. McLachlan · Proceedings of the National Academy of Sciences · 2001 · 178 citations · Full text

HBsAg Loss with Peg-interferon Alfa-2a in Hepatitis B Patients with Partial Response to Nucleos(t)ide Analog: New Switch Study

Peng Hu, Jia Shang, Wenhong Zhang et al. · Journal of Clinical and Translational Hepatology · 2018 · 157 citations · Full text